JBT Marel Corporation Reports First Quarter 2025 Results
First Quarter 2025 Highlights: (Results are from continuing operations)
-
Achieved quarterly orders of
and backlog of$916 million $1.3 billion
-
Revenue totaled
with more than half generated from recurring revenue$854 million
-
Earnings per share (EPS) was
and adjusted EPS was$(3.35) $0.97
-
Integration is on track, and the Company continues to expect to achieve
-$35 in realized cost synergies for the full year and$40 million -$80 in annualized run rate savings exiting 2025$90 million
"JBT Marel had a solid start to the year as we outperformed our first quarter expectations," said Brian Deck, Chief Executive Officer. "Orders continue to demonstrate the benefits of our diverse and holistic end-market solutions, with healthy demand in poultry, meat, beverages, pharmaceuticals, and pet food."
"The potential outcomes from global trade and tariff policies are creating increased uncertainty and costs, and we are taking proactive measures to mitigate impacts on our cost exposure, including vendor concessions, price increases, and reshoring of third party suppliers," added Deck.
Comparisons in this news release are to the comparable period of the prior year, unless otherwise noted. An earnings presentation with supplemental information is available on the Company's Investor Relations website at https://ir.jbtc.com/events-and-presentations/.
JBT Marel First Quarter 2025 Results
"Our team delivered strong operational execution, with solid equipment volume and expense management, leading to results that exceeded our guidance," said Matt Meister, Chief Financial Officer.
Beginning in the first quarter of 2025, the Company revised its adjusted income from continuing operations and adjusted EPS calculations to exclude acquisition related amortization expense. The Company believes this change better reflects its core operating earnings and improves comparability versus peers. Prior year periods have been recast to reflect this change.
First quarter 2025 consolidated revenue was
First quarter 2025 operating cash flow from continuing operations was
Comparison Summary of Segment and Combined Results
The below tables provide a summary, for comparison purposes, of certain first quarter 2025 and first quarter 2024 financial results for JBT and Marel segments as well as total combined JBT and Marel. The first quarter 2024 information contained in this table is not intended to represent pro forma financial information for JBT Marel as defined in Regulation S-X, Article 11.
|
Three Months Ended March 31, 2025 |
||||||||||
In millions except margin |
JBT |
|
Marel |
|
Total |
||||||
Revenue |
$ |
409 |
|
|
$ |
445 |
|
|
$ |
854 |
|
Adjusted EBITDA(1) |
|
61 |
|
|
|
51 |
|
|
|
112 |
|
Adjusted EBITDA margin |
|
14.9 |
% |
|
|
11.5 |
% |
|
|
13.1 |
% |
|
|
|
|
|
|
|
Three Months Ended March 31, 2024 |
||||||||||
In millions except margin |
JBT |
|
Marel (2) |
|
Total |
||||||
Revenue |
$ |
392 |
|
|
$ |
449 |
|
|
$ |
841 |
|
Adjusted EBITDA(1) |
|
57 |
|
|
|
43 |
|
|
|
100 |
|
Adjusted EBITDA margin |
|
14.6 |
% |
|
|
9.6 |
% |
|
|
11.9 |
% |
|
|
|
|
|
|
||||||
(1) Non-GAAP figure. Please see supplemental schedules for adjustments and reconciliations. |
|||||||||||
(2) Marel results for March 31, 2024, represent converted USD and |
Synergy Actions and Target Cost Savings
The Company remains on track to deliver expected in-year realized synergy savings of
For the full year 2025, the Company expects to incur
Additionally, the Company continues to advance its synergy savings from supply chain initiatives. Based on those supply chain efforts, JBT Marel continues to expect in-year savings of approximately
JBT Marel Outlook
As a result of macroeconomic uncertainty created by trade policies and tariffs, it is more difficult to ascertain the potential impact on global demand. As a result, the Company has suspended its full year 2025 guidance and chosen to provide second quarter 2025 guidance.
The below table reflects JBT Marel's consolidated guidance for the second quarter of 2025.
|
Guidance |
$ millions except EPS |
Q2 2025 |
Revenue |
|
Income from continuing operations |
|
Adjusted EBITDA(1) margin |
14.50 - |
GAAP EPS |
|
Adjusted EPS(1) |
|
|
|
(1) Non-GAAP figure. Please see supplemental schedules for adjustments and reconciliations. |
|
|
|
For the second quarter of 2025, the Company's consolidated revenue guidance includes a favorable
For the second quarter of 2025, the Company anticipates total depreciation and amortization expense to be approximately
JBT Marel expects that current tariff policies will create direct impacts to its cost of goods sold and is implementing short-term mitigation actions. Additionally, the Company believes that there could be impact to demand from the evolving tariff uncertainty. JBT Marel believes it is well positioned to maintain its global competitiveness as a result of its expansive global manufacturing footprint and holistic solutions offering. Please refer to the supplemental earnings presentation for incremental information.
Earnings Conference Call
A conference call is scheduled for 11:00 a.m. ET on Monday, May 5, 2025, to discuss first quarter 2025 results. A simultaneous webcast and audio replay of the call will be available on the Company’s Investor Relations website at https://ir.jbtc.com/events-and-presentations/.
JBT Marel Corporation (NYSE and Nasdaq Iceland: JBTM) is a leading global technology solutions provider to high-value segments of the food & beverage industry. JBT Marel brings together the complementary strengths of both the JBT and Marel organizations to transform the future of food. JBT Marel provides a unique and holistic solutions offering by designing, manufacturing, and servicing cutting-edge technology, systems, and software for a broad range of food and beverage end markets. JBT Marel aims to create better outcomes for customers by optimizing food yield and efficiency, improving food safety and quality, and enhancing uptime and proactive maintenance, all while reducing waste and resource use across the global food supply chain. JBT Marel employs approximately 11,700 people worldwide and operates sales, service, manufacturing and sourcing operations in more than 30 countries. For more information, please visit www.jbtmarel.com.
This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond JBT Marel's ability to control. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by JBT Marel will be achieved. These forward-looking statements include, among others, statements relating to our business and our results of operations, including our outlook, the benefits or results of our acquisition of Marel hf. (the "Marel Transaction"), our strategic plans, our restructuring plans and expected cost savings from those plans and our liquidity. The factors that could cause our actual results to differ materially from expectations include, but are not limited, to the following factors: the inability to successfully integrate the legacy businesses of JBT and Marel, operationally, technologically, culturally or otherwise, in a manner that permits the combined company to achieve the benefits and synergies anticipated from the Marel Transaction on the anticipated timeline or at all; fluctuations in our financial results; changes to trade regulation, quotas, duties or tariffs; unanticipated delays or accelerations in our sales cycles; deterioration of economic conditions, including impacts from supply chain delays and reduced material or component availability; inflationary pressures, including increases in energy, raw material, freight and labor costs; disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business; fluctuations in currency exchange rates; changes in food consumption patterns; impacts of pandemic illnesses, food borne illnesses and diseases to various agricultural products; weather conditions and natural disasters; the impact of climate change and environmental protection initiatives; acts of terrorism or war, including the ongoing conflicts in
JBT Marel provides non-GAAP financial measures in order to increase transparency in our operating results and trends. These non-GAAP measures eliminate certain costs or benefits from, or change the calculation of, a measure as calculated under
These calculations may differ from similarly-titled measures used by other companies. The non-GAAP financial measures disclosed are not intended to be used as a substitute for, nor should they be considered in isolation of, financial measures prepared in accordance with
JBT MAREL CORPORATION |
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME |
|||||||
(Unaudited and in millions, except per share data) |
|||||||
|
|
|
|
||||
|
Three Months Ended March 31, |
||||||
|
|
2025 |
|
|
|
2024 |
|
Revenue |
$ |
854.1 |
|
|
$ |
392.3 |
|
Cost of sales |
|
561.6 |
|
|
|
252.0 |
|
Gross profit |
|
292.5 |
|
|
|
140.3 |
|
Gross profit margin |
|
34.2 |
% |
|
|
35.8 |
% |
|
|
|
|
||||
Selling, general and administrative expense |
|
281.7 |
|
|
|
103.7 |
|
Research and development |
|
33.6 |
|
|
|
6.4 |
|
Restructuring expense |
|
10.6 |
|
|
|
1.1 |
|
Operating (loss) income |
|
(33.4 |
) |
|
|
29.1 |
|
Operating (loss) income margin |
|
(3.9 |
)% |
|
|
7.4 |
% |
|
|
|
|
||||
Pension expense, other than service cost |
|
146.8 |
|
|
|
1.0 |
|
Other income |
|
2.0 |
|
|
|
— |
|
Interest expense (income), net |
|
41.0 |
|
|
|
(2.8 |
) |
(Loss) income from continuing operations before income taxes |
|
(219.2 |
) |
|
|
30.9 |
|
Income tax provision |
|
(46.2 |
) |
|
|
8.1 |
|
Equity in net earnings of unconsolidated affiliate |
|
— |
|
|
|
(0.1 |
) |
(Loss) income from continuing operations |
|
(173.0 |
) |
|
|
22.7 |
|
Income from discontinued operations, net of taxes |
|
— |
|
|
|
0.1 |
|
Net (loss) income |
$ |
(173.0 |
) |
|
$ |
22.8 |
|
|
|
|
|
||||
Basic (loss) earnings per share from: |
|
|
|
||||
Continuing operations |
$ |
(3.35 |
) |
|
$ |
0.71 |
|
Discontinued operations |
|
— |
|
|
|
— |
|
Net (loss) income |
$ |
(3.35 |
) |
|
$ |
0.71 |
|
|
|
|
|
||||
Diluted (loss) earnings per share from net income from: |
|
|
|
||||
Continuing operations |
$ |
(3.35 |
) |
|
$ |
0.71 |
|
Discontinued operations |
|
— |
|
|
|
— |
|
Net (loss) income |
$ |
(3.35 |
) |
|
$ |
0.71 |
|
|
|
|
|
||||
Weighted average shares outstanding: |
|
|
|
||||
Basic |
|
51.7 |
|
|
|
32.0 |
|
Diluted |
|
51.7 |
|
|
|
32.2 |
|
|
|
|
|
||||
Other business information from continuing operations: |
|
|
|
||||
Inbound orders |
|
916.1 |
|
|
|
388.5 |
|
Orders backlog |
|
1,310.5 |
|
|
|
663.6 |
|
|
|
|
|
JBT MAREL CORPORATION |
|||||||||||||||||||
NON-GAAP FINANCIAL MEASURES |
|||||||||||||||||||
RECONCILIATION OF DILUTED EARNINGS PER SHARE TO ADJUSTED DILUTED EARNINGS PER SHARE |
|||||||||||||||||||
(Unaudited and in millions, except per share data) |
|||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Q1 2025 |
|
Q4 2024 |
|
Q3 2024 |
|
Q2 2024 |
|
Q1 2024 |
||||||||||
(Loss) income from continuing operations |
$ |
(173.0 |
) |
|
$ |
(6.9 |
) |
|
$ |
38.1 |
|
|
$ |
30.7 |
|
|
$ |
22.7 |
|
Non-GAAP adjustments |
|
|
|
|
|
|
|
|
|
||||||||||
Restructuring related costs(1) |
|
10.6 |
|
|
|
0.3 |
|
|
|
(0.2 |
) |
|
|
0.2 |
|
|
|
1.1 |
|
M&A related costs(2) |
|
74.4 |
|
|
|
53.3 |
|
|
|
12.9 |
|
|
|
14.5 |
|
|
|
5.2 |
|
Amortization of bridge financing debt issuance cost |
|
12.4 |
|
|
|
4.7 |
|
|
|
1.2 |
|
|
|
1.2 |
|
|
|
— |
|
Acquisition related amortization and depreciation |
|
41.7 |
|
|
|
11.4 |
|
|
|
11.0 |
|
|
|
11.1 |
|
|
|
11.1 |
|
Impact on tax provision from Non-GAAP adjustments(3) |
|
(31.0 |
) |
|
|
(16.7 |
) |
|
|
(6.3 |
) |
|
|
(6.8 |
) |
|
|
(4.3 |
) |
Recognition of non-cash pension plan related settlement costs |
|
146.9 |
|
|
|
23.3 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Impact on tax provision from non-cash pension plan related settlement costs |
|
(37.1 |
) |
|
|
(6.0 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Discrete tax adjustment from M&A activity |
|
5.4 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Deferred tax benefit related to an internal reorganization |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(8.8 |
) |
|
|
— |
|
Adjusted income from continuing operations |
$ |
50.3 |
|
|
$ |
63.4 |
|
|
$ |
56.7 |
|
|
$ |
42.1 |
|
|
$ |
35.8 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
(Loss) income from continuing operations |
$ |
(173.0 |
) |
|
$ |
(6.9 |
) |
|
$ |
38.1 |
|
|
$ |
30.7 |
|
|
$ |
22.7 |
|
Total shares and dilutive securities |
|
51.7 |
|
|
|
32.2 |
|
|
|
32.2 |
|
|
|
32.2 |
|
|
|
32.2 |
|
Diluted earnings per share from continuing operations |
$ |
(3.35 |
) |
|
$ |
(0.21 |
) |
|
$ |
1.18 |
|
|
$ |
0.95 |
|
|
$ |
0.71 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted income from continuing operations |
$ |
50.3 |
|
|
$ |
63.4 |
|
|
$ |
56.7 |
|
|
$ |
42.1 |
|
|
$ |
35.8 |
|
Total shares and dilutive securities |
|
51.9 |
|
|
|
32.2 |
|
|
|
32.2 |
|
|
|
32.2 |
|
|
|
32.2 |
|
Adjusted diluted earnings per share from continuing operations |
$ |
0.97 |
|
|
$ |
1.97 |
|
|
$ |
1.76 |
|
|
$ |
1.31 |
|
|
$ |
1.11 |
|
|
|
|
|
|
|
|
|
|
|
||||||||||
(1) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. |
|||||||||||||||||||
|
|||||||||||||||||||
(2) M&A related costs include integration costs, amortization of inventory step-up from business combinations, impacts of foreign currency derivatives and trades to hedge variability of exchange rates on the cash consideration paid for business combination, advisory and transaction costs for both potential and completed M&A transactions and strategy. M&A related costs are excluded as they are not part of the ongoing operations of our underlying business. |
|||||||||||||||||||
|
|||||||||||||||||||
(3) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown. |
|||||||||||||||||||
|
|||||||||||||||||||
The above table reports adjusted income from continuing operations and adjusted diluted earnings per share from continuing operations, which are non-GAAP financial measures. We use these measures internally to make operating decisions and for the planning and forecasting of future periods, and therefore provide this information to investors because we believe it allows more meaningful period-to-period comparisons of our ongoing operating results, without the fluctuations in the amount of certain costs that do not reflect our underlying operating results. |
JBT MAREL CORPORATION |
|||||||
NON-GAAP FINANCIAL MEASURES |
|||||||
RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA |
|||||||
(Unaudited and in millions) |
|||||||
|
|
|
|
||||
|
Three Months Ended March 31, |
||||||
|
|
2025 |
|
|
|
2024 |
|
(Loss) income from continuing operations |
$ |
(173.0 |
) |
|
$ |
22.7 |
|
Income tax provision |
|
(46.2 |
) |
|
|
8.1 |
|
Interest expense (income), net |
|
41.0 |
|
|
|
(2.8 |
) |
Other financing income(1) |
|
(2.0 |
) |
|
|
— |
|
Pension expense, other than service cost(2) |
|
146.8 |
|
|
|
1.0 |
|
Restructuring related costs(3) |
|
10.6 |
|
|
|
1.1 |
|
M&A related costs(4) |
|
74.4 |
|
|
|
5.2 |
|
Depreciation and amortization(5) |
|
60.6 |
|
|
|
22.1 |
|
Adjusted EBITDA from continuing operations |
$ |
112.2 |
|
|
$ |
57.4 |
|
|
|
|
|
||||
Total revenue |
$ |
854.1 |
|
|
$ |
392.3 |
|
Adjusted EBITDA margin |
|
13.1 |
% |
|
|
14.6 |
% |
|
|
|
|
||||
(1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing on this debt. |
|||||||
|
|
|
|
||||
(2) Pension expense, other than service cost is excluded as it represents all non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges. |
|||||||
|
|
|
|
||||
(3) Costs incurred as a direct result of the restructuring program are excluded because they are not part of the ongoing operations of our underlying business. |
|||||||
|
|
|
|
||||
(4) M&A related costs include integration costs, amortization of inventory step-up from business combinations, impacts of foreign currency derivatives and trades to hedge variability of exchange rates on the cash consideration paid for business combination, advisory and transaction costs for both potential and completed M&A transactions and strategy. M&A related costs are excluded as they are not part of the ongoing operations of our underlying business. |
|||||||
|
|
|
|
||||
(5) Depreciation and amortization, including the acquisition related amortization and depreciation expense, is excluded to determine EBITDA. |
|||||||
|
|
|
|
||||
The above table reports EBITDA and Adjusted EBITDA, which are non-GAAP financial measures. Given the Company’s focus on growth through acquisitions, management believes EBITDA facilitates an evaluation of business performance while excluding the impact of amortization due to the step up in value of intangible assets, and the depreciation of fixed assets. We use Adjusted EBITDA internally to make operating decisions and believe that adjusted EBITDA is useful to investors as a measure of the Company’s operational performance and a way to evaluate and compare operating performance against peers in the Company's industry. |
JBT MAREL CORPORATION |
|||||||||||
NON-GAAP FINANCIAL MEASURES |
|||||||||||
SEGMENT ADJUSTED EBITDA |
|||||||||||
(Unaudited and in millions) |
|||||||||||
|
|
|
|
|
|
||||||
|
Three Months Ended March 31, 2025 |
||||||||||
|
JBT |
|
Marel |
|
Total |
||||||
Segment adjusted EBITDA |
$ |
60.8 |
|
|
$ |
51.4 |
|
|
$ |
112.2 |
|
Segment revenue |
|
408.8 |
|
|
|
445.3 |
|
|
|
854.1 |
|
Segment adjusted EBITDA margin |
|
14.9 |
% |
|
|
11.5 |
% |
|
13.1 |
% |
JBT MAREL CORPORATION |
||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
(Unaudited and in millions) |
||||||
|
|
|
|
|||
|
March 31, 2025 |
|
December 31, 2024 |
|||
Assets |
|
|
|
|||
Cash and cash equivalents |
$ |
101.0 |
|
$ |
1,228.4 |
|
Restricted cash |
|
18.0 |
|
|
— |
|
Trade receivables, net of allowances |
|
543.9 |
|
|
335.1 |
|
Inventories |
|
613.5 |
|
|
233.1 |
|
Other current assets |
|
212.1 |
|
|
66.7 |
|
Total current assets |
|
1,488.5 |
|
|
1,863.3 |
|
Property, plant and equipment, net |
|
742.9 |
|
|
233.7 |
|
Goodwill |
|
2,834.1 |
|
|
769.1 |
|
Intangible assets, net |
|
2,621.9 |
|
|
340.9 |
|
Other assets |
|
311.9 |
|
|
206.8 |
|
Total assets |
$ |
7,999.3 |
|
$ |
3,413.8 |
|
|
|
|
|
|||
Liabilities and Stockholders' Equity |
|
|
|
|||
Short-term debt |
$ |
21.4 |
|
$ |
— |
|
Accounts payable, trade and other |
|
282.2 |
|
|
131.0 |
|
Advance and progress payments |
|
496.1 |
|
|
194.1 |
|
Other current liabilities |
|
383.7 |
|
|
210.4 |
|
Total current liabilities |
|
1,183.4 |
|
|
535.5 |
|
Long-term debt, less current portion |
|
1,966.1 |
|
|
1,252.1 |
|
Accrued pension and other post-retirement benefits, less current portion |
|
16.2 |
|
|
19.3 |
|
Other liabilities |
|
726.3 |
|
|
62.7 |
|
|
|
|
|
|||
Common stock and additional paid-in capital |
|
2,727.8 |
|
|
232.8 |
|
Retained earnings |
|
1,358.0 |
|
|
1,535.9 |
|
Accumulated other comprehensive loss |
|
21.5 |
|
|
(224.5 |
) |
Total stockholders' equity |
|
4,107.3 |
|
|
1,544.2 |
|
Total liabilities and stockholders' equity |
$ |
7,999.3 |
|
$ |
3,413.8 |
|
|
|
|
|
JBT MAREL CORPORATION |
|||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||
(Unaudited and in millions) |
|||||||
|
|
|
|
||||
|
Three Months Ended March 31, |
||||||
|
|
2025 |
|
|
|
2024 |
|
Cash flows from continuing operating activities |
|
|
|
||||
Net (loss) income |
$ |
(173.0 |
) |
|
$ |
22.8 |
|
Less: Income from discontinued operations, net of taxes |
|
— |
|
|
|
0.1 |
|
(Loss) income from continuing operations |
|
(173.0 |
) |
|
|
22.7 |
|
|
|
|
|
||||
Adjustments to reconcile income to cash provided by operating activities |
|
|
|
||||
Depreciation and amortization |
|
60.6 |
|
|
|
22.1 |
|
Stock-based compensation |
|
4.8 |
|
|
|
4.2 |
|
Other |
|
174.1 |
|
|
|
2.4 |
|
|
|
|
|
||||
Changes in operating assets and liabilities |
|
|
|
||||
Trade accounts receivable, net |
|
18.0 |
|
|
|
(14.2 |
) |
Inventories |
|
(12.9 |
) |
|
|
(13.2 |
) |
Accounts payable, trade and other |
|
20.9 |
|
|
|
8.6 |
|
Advance and progress payments |
|
31.8 |
|
|
|
(7.9 |
) |
Other - assets and liabilities, net |
|
(89.9 |
) |
|
|
(14.3 |
) |
Cash provided by continuing operating activities |
|
34.4 |
|
|
|
10.4 |
|
|
|
|
|
||||
Cash flows from continuing investing activities |
|
|
|
||||
Acquisitions, net of cash acquired |
|
(1,746.0 |
) |
|
|
— |
|
(Payments) proceeds from sale of AeroTech, net |
|
(0.2 |
) |
|
|
2.8 |
|
Capital expenditures |
|
(20.0 |
) |
|
|
(10.5 |
) |
Other |
|
0.6 |
|
|
|
0.5 |
|
Cash required by continuing investing activities |
|
(1,765.6 |
) |
|
|
(7.2 |
) |
|
|
|
|
||||
Cash flows from continuing financing activities |
|
|
|
||||
Net payments of domestic credit facilities, net of debt issuance cost |
|
(187.6 |
) |
|
|
— |
|
Proceeds from Term Loan B, net of debt issuance costs |
|
890.4 |
|
|
|
— |
|
Settlement of deal contingent hedge |
|
(42.5 |
) |
|
|
— |
|
Dividends |
|
(5.3 |
) |
|
|
(3.2 |
) |
Other |
|
(33.6 |
) |
|
|
(2.9 |
) |
Cash provided (required) by continuing financing activities |
|
621.4 |
|
|
|
(6.1 |
) |
|
|
|
|
||||
Net decrease in cash and cash equivalents from continuing operations |
|
(1,109.8 |
) |
|
|
(2.9 |
) |
Net cash required by discontinued operations |
|
— |
|
|
|
(0.2 |
) |
Effect of foreign exchange rate changes on cash and cash equivalents |
|
0.4 |
|
|
|
(1.2 |
) |
Net decrease in cash and cash equivalents |
|
(1,109.4 |
) |
|
|
(4.3 |
) |
|
|
|
|
||||
Cash and cash equivalents from continuing operations, beginning of period |
|
1,228.4 |
|
|
|
483.3 |
|
Add: Cash and cash equivalents from discontinued operations, beginning of period |
|
— |
|
|
|
— |
|
Add: Net decrease in cash and cash equivalents |
|
(1,109.4 |
) |
|
|
(4.3 |
) |
Less: Cash and cash equivalents from discontinued operations, end of period |
|
— |
|
|
|
— |
|
Cash and cash equivalents from continuing operations, end of period |
$ |
119.0 |
|
|
$ |
479.0 |
|
JBT MAREL CORPORATION |
|||||
NON-GAAP FINANCIAL MEASURES |
|||||
FREE CASH FLOW |
|||||
(Unaudited and in millions) |
|||||
|
|
|
|
||
|
Three Months Ended March 31, |
||||
|
2025 |
|
2024 |
||
Cash provided by continuing operating activities |
$ |
34.4 |
|
$ |
10.4 |
Less: capital expenditures |
|
20.0 |
|
|
10.5 |
Plus: proceeds from disposal of assets |
|
0.6 |
|
|
0.5 |
Plus: pension contributions |
|
2.8 |
|
|
0.3 |
Free cash flow (FCF) |
$ |
17.8 |
|
$ |
0.7 |
|
|
|
|
||
The above table reports free cash flow, which is a non-GAAP financial measure. We use free cash flow internally as a key indicator of our liquidity and ability to service debt, invest in business combinations, and return money to shareholders and believe this information is useful to investors because it provides an understanding of the cash available to fund these initiatives. For free cash flow purposes, we consider contributions to pension plans to be more comparable to payment of debt, and therefore exclude these contributions from the calculation of free cash flow. Additionally, we exclude the income taxes on gain from sale of AeroTech as these represent one-time taxes paid on the sale of a discontinued operation that are not representative of taxes from operations. |
JBT MAREL CORPORATION |
|||||||||||||||||
NET DEBT CALCULATION |
|||||||||||||||||
(Unaudited and in millions) |
|||||||||||||||||
|
|
|
|
|
|
|
|
|
|
||||||||
|
As of Quarter Ended |
|
Change From |
||||||||||||||
|
Q1 2025 |
|
Q4 2024 |
|
Q1 2024 |
|
PQ |
|
PY |
||||||||
Total debt |
$ |
1,987.5 |
|
|
$ |
1,252.1 |
|
|
$ |
647.0 |
|
|
$ |
735.4 |
|
$ |
1,340.5 |
Cash and marketable securities |
|
(101.0 |
) |
|
|
(1,228.4 |
) |
|
|
(479.0 |
) |
|
|
1,127.4 |
|
|
378.0 |
Net debt |
$ |
1,886.5 |
|
|
$ |
23.7 |
|
|
$ |
168.0 |
|
|
$ |
1,862.8 |
|
$ |
1,718.5 |
|
|
|
|
|
|
|
|
|
|
||||||||
|
JBT MAREL CORPORATION |
|||
BANK TOTAL NET LEVERAGE RATIO CALCULATION |
|||
(Unaudited and in millions) |
|||
|
|
||
|
Q1 2025 |
||
Total debt |
$ |
1,987.5 |
|
Cash and marketable securities |
|
(101.0 |
) |
Net debt |
|
1,886.5 |
|
Other items considered debt under the credit agreement |
|
37.9 |
|
Consolidated total indebtedness(1) |
$ |
1,924.4 |
|
|
|
||
Trailing twelve months Adjusted EBITDA from continuing operations |
|
349.8 |
|
Pro forma EBITDA of recent acquisitions(2) |
|
141.2 |
|
Trailing twelve months pro forma adjusted EBITDA |
|
491.0 |
|
Other adjustments net to earnings under the credit agreement |
|
105.1 |
|
Consolidated EBITDA(1) |
$ |
596.1 |
|
|
|
||
Bank total net leverage ratio (Consolidated Total Indebtedness / Consolidated EBITDA) |
|
3.2 |
|
|
|
||
Total net debt to trailing twelve months Adjusted EBITDA from continuing operations |
|
3.8 |
|
|
|
||
(1) As defined in the credit agreement. |
|||
|
|
||
(2) Pro forma EBITDA related to the acquisitions in the prior twelve months |
|
JBT MAREL CORPORATION |
|
NON-GAAP FINANCIAL MEASURES |
|
RECONCILIATION OF DILUTED EARNINGS PER SHARE FROM CONTINUING OPERATIONS |
|
TO ADJUSTED DILUTED EARNINGS PER SHARE GUIDANCE |
|
(Unaudited and in cents) |
|
|
|
|
Guidance |
|
Q2 2025 |
Diluted earnings per share from continuing operations |
|
Non-GAAP adjustments |
|
Restructuring related costs(1) |
0.21 |
M&A related costs(2) |
0.35 |
Acquired asset depreciation and amortization(3) |
0.79 |
Impact on tax provision from Non-GAAP adjustments(5) |
(0.35) |
Adjusted diluted earnings per share from continuing operations |
|
|
|
JBT MAREL CORPORATION |
|
NON-GAAP FINANCIAL MEASURES |
|
RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED EBITDA GUIDANCE |
|
(Unaudited and in millions) |
|
|
Guidance |
|
Q2 2025 |
(Loss) from continuing operations |
|
Income tax provision |
|
Interest expense, net |
~ 27.0 |
Other financing income(4) |
~ (3.0) |
Restructuring related costs(1) |
~ 11.0 |
M&A related costs(2) |
~ 18.0 |
Depreciation and amortization |
~ 61.0 |
Adjusted EBITDA from continuing operations |
|
|
|
(1) Restructuring related costs is estimated to be approximately |
|
|
|
(2) M&A related costs are estimated to be approximately |
|
|
|
(3) Acquired asset depreciation and amortization is expected to be |
|
|
|
(4) Other financing income is estimated to be approximately |
|
|
|
(5) Impact on tax provision for the second quarter of 2025 was calculated using a tax rate of approximately 24 - |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250502212195/en/
Investors & Media:
Marlee Spangler
JBTMarel.IR@jbtc.com
+1 (312) 861-5784
Source: JBT Marel Corp